1. Introduction
===============

Gastric cancer is the fifth most frequent cancer worldwide and the third most common cause of death from cancer.^\[[@R1]\]^ Gastric cancer accounted for 5.7% of all cancer cases and 8.2% of all cancer-related mortality, with 782,685 deaths, in 2018, thus posing a serious threat to human life and health.^\[[@R1]\]^

Radical surgery is the only definitive treatment method for gastric cancer.^\[[@R2]\]^ It has been approximately 25 years since Kitano completed the first laparoscopic distal gastrectomy (LDG) in the world in 1994, and its advantage of minimal invasiveness is becoming increasingly accepted.^\[[@R3]\]^ LDG and laparotomy have different surgical approaches, and whether experience gained from laparotomy can be applied to LDG is questionable. Given the wide application of LDG, it is essential to reappraise the reconstruction procedures used in pure laparoscopic surgery.

Several reconstruction procedures (Billroth I (B-I), Billroth II (B-II), Roux-en-Y (RY), and uncut Roux-en-Y (URY) anastomoses) are selectively performed after LDG, according to the choice of individual surgeons. To date, only a few meta-analyses^\[[@R4]--[@R6]\]^ have investigated reconstruction procedures after distal gastrectomy. A meta-analysis by Xiong et al^\[[@R4]\]^ in 2013 reported that RY anastomosis had some clinical advantages over B-I anastomosis, and in 2018, an NMA by Cai et al^\[[@R5]\]^ indicated that RY anastomosis was superior to B-I and B-II anastomoses in terms of preventing bile reflux and remnant gastritis. However, a recent meta-analysis by Sun et al^\[[@R6]\]^ in 2018 demonstrated that URY anastomosis is clinically superior to RY anastomosis. Therefore, there is a lack of consensus on which reconstruction method is better. None of the 3 meta-analyses had simultaneously compared 4 anastomosis methods, and they also failed to distinguish laparoscopic surgery from laparotomy.

Thus, we performed a network meta-analysis (NMA), a new analysis method that can both provide comparisons of treatment effects and rank all treatments,^\[[@R7]\]^ comparing four different reconstruction methods to evaluate both the short-term outcomes and the long-term endoscopic findings after LDG.

2. Materials and methods
========================

2.1. Search strategy
--------------------

Our NMA was conducted based on the PRISMA statement^\[[@R8]\]^ and its extension statement for network meta-analyses^\[[@R9]\]^ to search all relevant studies. Three electronic databases, namely, EMBASE, PubMed and the Cochrane Library, were methodically searched for articles published up to November 2018 with the following combination of keywords and their variants: "laparoscopy", "stomach neoplasm", "gastroenterostomy", "anastomosis, Roux-en-Y", and "Billroth". The detailed search strategy for PubMed is shown in Supplementary Fig. 1, and search strategies for EMBASE and the Cochrane Library were similar to it. Additional articles were also checked from the references of the included studies.

2.2. Study selection
--------------------

The following criteria were used for study selection: Participants: Patients with a pathological diagnosis of primary gastric cancer without metastasis or invasion into adjacent organs and with sufficient cardiopulmonary function to tolerate surgery; interventions and comparisons: only original articles comparing 2 or more different reconstruction procedures (B-I, B-II, RY, and URY anastomoses) after LDG were considered for inclusion, regardless of total laparoscopic surgery or laparoscopic-assist surgery; outcomes: the study needed to report at least one of the following outcomes: operative time, blood loss, anastomotic complication, gastrointestinal motility dysfunction, food residue, remnant gastritis and bile reflux; study design: both randomized controlled trials (RCTs) and nonrandomized controlled trials were included due to the lack of high-quality RCTs.

In the case of the same results reported 2 or more times, only the newest publications were included. Literature selection was agreed upon by 2 independent reviewers, and any the disagreements were resolved by consultation with a third reviewer.

2.3. Data extraction and quality assessment
-------------------------------------------

The required information, including population characteristics (country, design, study year, mean age, sex, and tumor characteristics) and outcome factors (blood loss, operative time, anastomotic leakage, anastomotic bleeding, anastomotic stenosis, gastrointestinal motility dysfunction, food residue, remnant gastritis, and bile reflux), was independently extracted by 2 reviewers using the same form. Any conflicts between the 2 reviewers were resolved thorough discussions with another reviewer.

The risk of bias for the included studies was assessed by 2 independent authors using the Newcastle-Ottawa scoring system.^\[[@R10]\]^

2.4. Data analysis
------------------

For categorical data, treatment effects were expressed as odds ratios (ORs) and 95% confidence intervals (95%CIs). For continuous data, treatment effects were expressed as standardized mean differences (SMDs) and 95%CIs. Surface under the cumulative ranking curve (SUCRA) was used to calculate the hierarchy of treatments for each intervention. The SUCRA value ranges from 0 to 1, and a higher SUCRA value indicates a better efficacy.^\[[@R11]\]^ Comparison-adjusted funnel plots were used to identify publication bias and small-study effects. Inconsistency was evaluated using an inconsistency check ('ifplot' procedure of Stata version 13.0). Discrepancies between direct comparison and network comparison were also utilized to identify inconsistency. WinBUGS version 1.4.3 software and statistical model described by Chaimani et al^\[[@R12]\]^ with a random-effects model were used to perform our NMA. Graphs of the statistical results obtained from WinBUGS version 1.4.3 software were generated by Stata version 13.0 and GraphPad Prism version 7.0a.

All of the information we considered was extracted from published papers, so it was not necessary to obtain ethical approval.

3. Results
==========

3.1. Study characteristics
--------------------------

After a comprehensive inspection, 17 retrospective studies^\[[@R13]--[@R29]\]^ and 1 RCT^\[[@R30]\]^ were included in our NMA (Fig. [1](#F1){ref-type="fig"}). One study simultaneously compared B-I, B-II, RY, and URY anastomoses; 3 studies compared B-I and B-II anastomoses; 8 studies compared B-I and RY anastomoses; 2 studies compared B-I and URY anastomoses; 3 studies compared B-II and RY anastomoses; and 1 study compared B-II and URY anastomoses. Table [1](#T1){ref-type="table"} shows the characteristics of these studies. In total, 4347 patients were included in our analysis: 2362 were treated with B-I anastomosis; 1132 were treated with B-II anastomosis; 714 were treated with RY anastomosis; and 139 were treated with URY anastomosis.

![Flow diagram for the identification of eligible studies. RCT = randomized controlled trial.](medi-98-e18381-g001){#F1}

###### 

The characteristics of the included researches.
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A network graph of the included studies is shown in Figure [2](#F2){ref-type="fig"}. Four nodes were compared in the network graph, in which the size of the nodes was associated with the number of patients undergoing a certain type of anastomosis, and the thickness of the lines was related to the number of direct comparisons between 2 reconstruction methods. The Newcastle-Ottawa scoring system (Table [2](#T2){ref-type="table"}) showed high quality without obvious bias among the studies. Comparison-adjusted funnel plots (Supplementary Fig. 2) followed a symmetrical distribution, and no obvious publication bias was identified.

![Network graph of the included studies. B-I = Billroth I anastomosis, B-II = Billroth II anastomosis, RY = Roux-en-Y anastomosis, URY = uncut Roux-en-Y anastomosis.](medi-98-e18381-g003){#F2}
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The risk of bias among included researches using the Newcastle-Ottawa Scale.
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3.2. NMA results
----------------

### 3.2.1. Short-term outcomes

Short-term outcomes, including operative time, blood loss, time to first flatus, time to first soft diet, length of hospital stay, anastomotic leakage, anastomotic stenosis, anastomotic bleeding, and gastrointestinal motility dysfunction, were measured. If ileus, delayed gastric emptying or Roux stasis syndrome (RSS) were observed, gastrointestinal motility dysfunction could be diagnosed.

*Operative time:* Operative time was extracted from 14 studies.^\[[@R13]--[@R15],[@R17],[@R18],[@R20],[@R22],[@R24]--[@R30]\]^ The NMA results (Fig. [3](#F3){ref-type="fig"}) showed that RY anastomosis had a significantly longer operative time than B-I (SMDs: 0.74, 95%CIs: 0.44, 1.01) and B-II (SMDs: 0.53, 95%CIs: 0.20, 0.86) anastomoses. Nevertheless, no significant differences were found among the other reconstructive methods. SUCRA plots indicated that RY anastomosis had the highest probability of being the worst method for reducing operative time (SUCRA = 0.9%), while B-I anastomosis had the highest probability of being the best method (SUCRA = 92.1%), followed by B-II (SUCRA = 56.2%) and URY (SUCRA = 50.7%) anastomoses (Supplementary Fig. 4). No obvious differences were discovered between network comparison and direct comparison, and no significant differences were detected by the inconsistency check (Supplementary Fig. 3).

![Results of network and direct comparisons between different reconstructions. B-I = Billroth I anastomosis, B-II = Billroth II anastomosis, OR = odds ratio, RY = Roux-en-Y anastomosis, SMD = standardized mean difference, URY = uncut Roux-en-Y anastomosis. The columns represent direct comparisons, and the rows represent all network comparisons.](medi-98-e18381-g005){#F3}

*Blood loss:* Blood loss was investigated in 11 studies.^\[[@R13],[@R14],[@R17],[@R18],[@R20],[@R22],[@R24],[@R25],[@R27],[@R28],[@R30]\]^ The NMA results (Fig. [3](#F3){ref-type="fig"}) demonstrated that URY anastomosis was significantly superior to RY anastomosis in reducing blood loss (SMDs: --0.68, 95%CIs: --1.30, --0.05). However, no significant differences were found among the other reconstruction methods. SUCRA plots (Supplementary Fig. 4) indicated that URY anastomosis had the highest probability of being the best method for reducing blood loss (SUCRA = 95.0%), followed by B-II (SUCRA = 53.2%) and B-I (SUCRA = 41.6%) anastomoses. In contrast, RY anastomosis had the highest probability of being the worst method for reducing blood loss (SUCRA = 10.0%). Network and direct comparison results were mostly comparable, and no significant differences were detected by the inconsistency check (Supplementary Fig. 3).

*Anastomotic leakage, anastomotic bleeding, and anastomotic stenosis:* The NMA results (Fig. [3](#F3){ref-type="fig"}) showed no significant differences among B-I, B-II, RY, and URY anastomoses in terms of anastomotic leakage, anastomotic bleeding or anastomotic stenosis. However, the ORs and 95%CIs in the NMA between URY anastomosis and other anastomoses were substantially large, which might be due to small sample effects. Although no significant differences were found by the inconsistency check among B-I, B-II and RY anastomoses, we failed to obtain a comparison loop containing URY anastomosis (Supplementary Fig. 3).

*Gastrointestinal motility dysfunction:* Gastrointestinal motility dysfunction was investigated in 15 studies.^\[[@R13]--[@R15],[@R18],[@R19],[@R21]--[@R30]\]^ The NMA results (Fig. [3](#F3){ref-type="fig"}) demonstrated a significant superiority of B-I anastomosis to RY anastomosis (ORs: 0.35, 95%CIs: 0.12, 0.77). Nonetheless, no significant differences were found among the other reconstructive methods. Network comparison and direct comparison yielded very similar results, and no significant differences were found by the inconsistency check (Supplementary Fig. 3). SUCRA plots (Supplementary Fig. 4) showed that B-I anastomosis had the highest probability of being the best method for preventing gastrointestinal motility dysfunction (SUCRA = 88.1%), followed by URY (SUCRA = 58.1%) and B-II (SUCRA = 38.3%) anastomoses. In contrast, RY anastomosis had the lowest probability of being the best method for preventing gastrointestinal motility dysfunction (SUCRA = 15.4%).

### 3.2.2. Long-term endoscopic findings

Long-term endoscopic findings were measured by postoperative endoscopy at 1 year after LDG. These outcomes were categorized according to the "residue, gastritis, bile" (RGB) classification proposed by Kubo et al.^\[[@R31]\]^ Nine studies^\[[@R13],[@R14],[@R17],[@R21],[@R23],[@R27]--[@R30]\]^ reported long-term endoscopic findings; 1 study simultaneously compared B-I, B-II, RY, and URY anastomoses; 1 study compared B-I and B-II anastomoses; 3 studies compared B-I and RY anastomoses; 3 studies compared B-II and RY anastomoses; and 1 study compared B-II and URY anastomoses.

*Food residue:* The NMA results (Fig. [3](#F3){ref-type="fig"}) indicated a significant superiority of URY anastomosis to B-I (ORs: 0.05, 95%CIs: 0.01, 0.59), B-II (ORs: 0.07, 95%CIs: 0.01, 0.84) and RY (ORs: 0.05, 95%CIs: 0.01, 0.67) anastomoses for preventing food residue. However, no significant differences were found among the other 3 reconstructive methods. Network comparison and direct comparison yielded very similar results, and no significant differences were found by the inconsistency check (Supplementary Fig. 3). SUCRA plots (Supplementary Fig. 4) indicated that URY anastomosis had the highest probability of being the best method for decreasing food residue (SUCRA = 98.9%), followed by B-II (SUCRA = 48.1%), RY (SUCRA = 28.2%) and B-I (SUCRA = 24.6%) anastomoses.

*Remnant gastritis:* The NMA results (Fig. [3](#F3){ref-type="fig"}) indicated a significant superiority of RY anastomosis to B-I (ORs: 0.11, 95%CIs: 0.05, 0.30) and B-II (ORs: 0.06, 95%CIs: 0.02, 0.18) anastomoses and a significant superiority of URY anastomosis to B-II anastomosis (ORs: 0.13, 95%CIs: 0.04, 0.52) for preventing remnant gastritis. Nevertheless, no significant differences were found among the other reconstruction methods. Network comparison and direct comparison were yielded very similar results, and no significant differences were found by the inconsistency check (Supplementary Fig. 3). SUCRA plots (Supplementary Fig. 4) indicated that RY anastomosis had the highest probability of being the best method for decreasing remnant gastritis (SUCRA = 95.9%), followed by URY (SUCRA = 69.3%) and B-I (SUCRA = 30.6%) anastomoses. In contrast, B-II anastomosis had the lowest probability of being the best method for preventing remnant gastritis (SUCRA = 4.0%).

*Bile reflux:* The NMA results (Fig. [3](#F3){ref-type="fig"}) indicated that both RY and URY anastomoses were significantly superior to B-I (ORs: 0.09, 95%CIs: 0.04, 0.25 and ORs: 0.06, 95%CIs: 0.01, 0.48, respectively) and B-II (ORs: 0.05, 95%CIs: 0.02, 0.15 and ORs: 0.04, 95%CIs: 0.01, 0.23, respectively) anastomoses in preventing bile reflux. However, no significant differences were found between either B-I and B-II anastomoses or between RY and URY anastomoses. Network comparison and direct comparison yielded very similar results, and no significant differences were found by the inconsistency check (Supplementary Fig. 3). SUCRA plots (Supplementary Fig. 4) showed that URY anastomosis had the highest probability of being the best method for preventing bile reflux (SUCRA = 84.7%), followed by RY (SUCRA = 81.8%) and B-I (SUCRA = 28.1%) anastomoses. In contrast, B-II anastomosis had the lowest probability of being the best method for preventing bile reflux (SUCRA = 5.2%).

4. Discussion
=============

In our NMA, we evaluated four reconstruction procedures in 4347 patients who underwent LDG. This is the first NMA to simultaneously compare 4 anastomoses after LDG.

B-I anastomosis is widely used because it conforms to physiological pathways, but due to strong anastomotic tension and a high risk of anastomotic leakage, it cannot be implemented in all patients.^\[[@R32]\]^ B-II anastomosis relieves anastomotic tension, but it results in the most postoperative complications due to changes in the normal physiological pathway.^\[[@R33]\]^ RY anastomosis decreases the rate of common postoperative complications; nevertheless, it causes RSS.^\[[@R34]\]^ In contrast, URY anastomosis can reduce the risk of RSS, but it carries the risk of recanalization of the uncut stapled line.^\[[@R35]\]^

Roughly, in our NMA, RY anastomosis performed poorly for decreasing operative time and blood loss. Nevertheless, RY and URY anastomoses were better than B-I and B-II anastomoses for preventing adverse long-term endoscopic findings.

RY anastomosis involves one more anastomotic site than B-I and B-II anastomoses. In addition, in RY anastomosis, the mesentery needs to be separated, and mesenteric vessels need to be manipulated, unlike in B-I, B-II, or URY anastomosis.^\[[@R5],[@R6]\]^ Therefore, a significantly longer operative time and greater blood loss occur with RY anastomosis. These results are consistent with the results of previous meta-analyses.^\[[@R4]--[@R6]\]^

The OR values for URY anastomosis and the other methods were quite large, which compelled us to consider small sample effects. A possible explanation is that only 2 studies^\[[@R25],[@R26]\]^ with 19 patients analyzed URY anastomosis with regards to anastomotic complications, and one^\[[@R26]\]^ of them was excluded from the network analysis because of the lack of positive results between groups with and without complications. Furthermore, no positive events were observed with URY anastomosis in the remaining study,^\[[@R25]\]^ which decreased comparability between URY anastomosis and the other methods. A recent meta-analysis^\[[@R6]\]^ indicated that URY anastomosis preserved mesenteric continuity and ensured blood supply to the anastomotic site. However, the authors also failed to find a significant difference between RY and URY anastomoses in terms of anastomotic complications. They attributed this lack of difference to the use of cutting-edge technology and a stapling technique.^\[[@R6]\]^

A previous NMA^\[[@R5]\]^ indicated that B-I anastomosis could be more effective than RY anastomosis for preventing gastrointestinal motility dysfunction because RY anastomosis destroys the physiological continuity of the gastrointestinal tract; this is consistent with our results. RSS, which influences the quality of life of patients, is a gastrointestinal motility dysfunction that is often encountered by surgeons using RY anastomosis.^\[[@R36]--[@R39]\]^ A recent meta-analysis^\[[@R6]\]^ demonstrated that for laparotomy, URY anastomosis performed better than RY anastomosis (ORs: 0.14, 95%CIs: 0.04, 0.50) for reducing the risk of RSS by maintaining the completeness and normal electrophysiological conduction of the small intestine. Although the SUCRA value of URY anastomosis was than higher than that of RY anastomosis for preventing gastrointestinal motility dysfunction in our NMA, we failed to find a significant difference. A possible explanation could be that RSS is usually observed in RY anastomosis with limbs longer than 40 cm, as demonstrated by Gustavsson et al.^\[[@R40]\]^ In the studies we included,^\[[@R19],[@R21],[@R23],[@R24],[@R27]--[@R29]\]^ the limb length was less than 40 cm.

For preventing food residue, URY anastomosis was more effective than the other methods because URY anastomosis has the advantages of maintaining intestinal integrity, good blood flow at the anastomotic site and normal intestinal peristalsis.^\[[@R41]\]^ For preventing bile reflux, a significant superiority of RY and URY anastomoses to B-I and B-II anastomoses was shown because after URY or RY anastomosis, bile can flow into the excurrent jejunal limb through the second anastomotic site.^\[[@R5]\]^ Remnant gastritis is associated with gastric stump carcinoma.^\[[@R42]\]^ Regarding remnant gastritis, RY and URY anastomoses yielded better results. A possible explanation could be that RY and URY anastomoses have a good anti-reflux ability, which protects the stomach from bile encroachment.^\[[@R4]\]^ Taking all the aforementioned results into consideration, we concluded that URY and RY anastomoses were better than B-I and B-II anastomoses in terms of long-term endoscopic findings.

Nonetheless, there are several limitations of our analysis. First, only 4 studies with 139 patients had investigated URY anastomosis, which may have caused a certain bias due to the small sample size. Third, our results were mostly based on retrospective studies and may have been influenced by inherent selection bias. Furthermore, we did not compare other important outcomes such as body weight change, amount of ingested food and various postgastrectomy symptoms due to a lack of original literature.

5. Conclusion
=============

Both RY and URY anastomoses are superior to B-I and B-II anastomoses in terms of long-term endoscopic findings after LDG. URY anastomosis shows superiority to RY anastomosis in reducing operative blood loss. Furthermore, RY anastomosis is worse than B-I anastomosis in decreasing operative time and preventing gastrointestinal motility dysfunction. Therefore, URY anastomosis seems to be a favorable reconstruction method after LDG due to its superiority because of operative simplicity and fewer long-term complications. However, large prospective multicenter studies and well-designed RCTs, especially for URY anastomosis, are recommended for further validation of this conclusion.
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